Aida Pharmaceuticals Profit Margin

The latest profit margin for AIDA is -5.11% as of September 2008. That compares with 1.62% in the prior-year period — down 416.5% year over year. That is below the sector sector average of 13.16%. Investors often review this figure alongside Aida Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, AIDA's profit margin moved from 1.62% to -5.11% — a 416.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aida Pharmaceuticals's valuation or profitability profile.

Against its sector companies, AIDA currently prints -5.11% for profit margin, while the sector average sits near 13.16%. That is roughly 138.8% below the sector mean. Large gaps often invite a closer look at Aida Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Aida Pharmaceuticals converts resources into returns. At -5.11%, AIDA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 1.62% in the prior-year period — down 416.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AIDA's profit margin (-5.11%), review year-over-year change from 1.62%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.